Snowden Capital Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,000
Closed -$218K 1206
2023
Q4
$218K Hold
6,000
0.01% 1047
2023
Q3
$290K Sell
6,000
-73
-1% -$4.34K 0.01% 875
2023
Q2
$415K Hold
6,073
0.01% 821
2023
Q1
$294K Sell
6,073
-25
-0.4% -$1.32K 0.01% 947
2022
Q4
$367K Buy
+6,098
New +$357K 0.02% 849

Other funds holding PRTA

Snowden Capital Advisors's PRTA Position: Q1 2024 in Review

Snowden Capital Advisors sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 6,000 shares — an estimated $218K sold.

Snowden Capital Advisors first reported a position in PRTA in Q4 2022 and held it in 5 quarters. The position peaked at $415K in Q2 2023. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

  • Snowden Capital Advisors reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 6,000 Prothena Corp shares in Q1 2024, an estimated $218K.
  • Snowden Capital Advisors first reported a position in Prothena Corp in Q4 2022 and held it in 5 quarters.
  • Snowden Capital Advisors's Prothena Corp position peaked at $415K in Q2 2023.
  • 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on Snowden Capital Advisors's 13F filing for Q1 2024, filed 15 May 2024.